APDN - Applied DNA Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
9/29/2018
9/29/2017
9/29/2016
Total Revenue
4,912
3,903
4,751
4,186
Cost of Revenue
808
1,207
1,077
747
Gross Profit
4,103
2,697
3,674
3,440
Operating Expenses
Research Development
2,797
2,752
2,282
3,694
Selling General and Administrative
11,590
11,043
13,325
11,239
Total Operating Expenses
14,829
14,343
16,494
15,640
Operating Income or Loss
-10,726
-11,646
-12,820
-12,200
Interest Expense
-
10
-
-
Total Other Income/Expenses Net
-32
-37
-38
13
Income Before Tax
-10,874
-11,693
-12,856
-12,176
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-10,874
-11,693
-12,856
-12,176
Net Income
-10,874
-11,693
-12,856
-12,176
Net Income available to common shareholders
-10,874
-11,693
-12,856
-12,176
Reported EPS
Basic
-
-16.00
-19.60
-20.40
Diluted
-
-16.00
-19.60
-20.40
Weighted average shares outstanding
Basic
-
737
659
592
Diluted
-
737
659
592
EBITDA
-
-11,136
-11,933
-11,493